TNDM - Tandem Diabetes Care Inc logo

Tandem Diabetes Care Inc

TNDM

Tandem Diabetes Care designs and sells insulin delivery technology for diabetes management, including the t:slim X2 and Tandem Mobi insulin pumps. The company also offers related products like cartridges, infusion sets, and data management platforms.

โš•๏ธ Healthcare NASDAQ Listed 2013 $ USD
$1,000 invested 10 years ago โ†’$215today

Score Overview

1 Year
Score
Net Growth69.07%
Net TrendGrew
Net Income Consistencyโ€”
Rev Growth2.63%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score3.8
Net Growth-4x
Net Trend40%
Net Income Consistencyโ€”
Rev Growth48.18%
Rev Trend80%
Revenue Consistencyโ€”
10 Years
Score
Net Growth24.13%
Net Trend50%
Net Income Consistency
Rev Growth12x
Rev Trend90%
Revenue Consistency
All Time
Score
Net Growth-0.28%
Net Trend46%
Net Income Consistency
Rev Growth35x
Rev Trend92%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Tandem Diabetes Care Inc has ranked, year by year

Measure
Fundamentals Window

Not enough ranking history to display a chart

This chart needs at least two years of available HDB Score rankings on 20 years of fundamentals. TNDM does not have enough ranked years in the public Archive through 2021.

More recent Archive years are available with Membership. Coverage varies by company and measure.

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-10-01
$ 16.50โ€”
1 Year2025-10-01
$ 12.4132.96%
5 Years2021-10-01
$ 121.18-86.38%
10 Years2016-09-30
$ 76.60-78.46%
All Time2013-11-14
$ 192.60-91.43%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 1.04B-$ 63M$ 455M
2025$ 1.01B-$ 204M$ 292M
2024$ 940M-$ 96M$ 438M
2023$ 747M-$ 222M$ 467M
2022$ 801M-$ 94M$ 616M
2021$ 702M$ 15M$ 623M
2020$ 498M-$ 34M$ 484M
2019$ 362M-$ 24M$ 176M
2018$ 183M-$ 122M$ 129M
2017$ 107M-$ 73M$ 14M
2016$ 84M-$ 83M$ 53M
2015$ 72M-$ 72M$ 71M
2014$ 49M-$ 79M$ 67M
IPO2013$ 29M-$ 63M$ 129M
TNDM - Tandem Diabetes Care Inc logo

Tandem Diabetes Care Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 498M to $ 1.01B and net income went from -$ 34M to -$ 204M. Revenue increased in 4 of those 5 years; net income in 2.

Across Tandem Diabetes Care Inc's full reported history, from 2013 to 2025, revenue grew from $ 29M to $ 1.01B and net income went from -$ 63M to -$ 204M. Revenue increased in 92% of the years measured; net income in 46%.

Tandem Diabetes Care Inc currently holds a 5-year HDB Score of 3.8 out of 10. How the HDB Score is calculated.

Membership

Explore TNDM with current data

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,813 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year ยท Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies